Trial intelligence / Profile preview

Mirabegron effect on urethral pressure variations during urodynamic testing

NL-OMON26653Recruiting

Sponsor
P. Groenendijk
Start
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of mirabegron in overactive bladder (OAB), sponsored by P. Groenendijk. Started Nov 2014; status: recruiting.

02

Drugs

mirabegron
03

Conditions

overactive bladder (OAB)

Beyond the preview

Go deeper on NL-OMON26653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call